Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.

Product Documentation

Details, specifications, and documents

Description

Tesamorelin 20 mg: research material

Buy Tesamorelin 20 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

Tesamorelin is a modified analogue of growth hormone-releasing hormone (GHRH). Its reference structure has 44 amino acids and an added hexenoyl group at the N-terminus, one end of the peptide chain.

Choose the material and presentation

This is single-compound Tesamorelin, distinct from Sermorelin and from the Tesamorelin + Ipamorelin blend. The latter’s total includes two components.

Other presentations: Tesamorelin 5 mg, Tesamorelin 10 mg.

Tesamorelin identity and analytical research

In the cited study, researchers used antibody capture followed by high-resolution tandem mass spectrometry to identify GHRH-related peptides in plasma. The structural comparison distinguishes 44-residue Tesamorelin from the shorter Sermorelin 1-29 fragment.

The two peptides showed different degradation behavior in the tested plasma conditions. These observations help analytical researchers distinguish starting compounds from metabolites. They do not establish a storage temperature, expiration date or stability specification for a supplied vial.

Original study

Product records and batch reports

Open the COA and documents tab for the available batch reports and product files. Match the product and lot, then read identity, purity and measured content as separate results.

Additional information

CAS No.

218949-48-5

Purity

≥99%

Molecular Formula

C221H366N72O67S (reference free peptide; excludes counterions and fillers)

Molecular Weight

5135.9 g/mol (reference free peptide; excludes counterions and fillers)

Applications

Visceral fat reduction studies, growth hormone secretion research, metabolic disorder models

Synthesis

Solid-phase synthesis

Format

Lyophilized powder

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C.

Appearance

White lyophilized powder

Shipping Conditions

Shipped at ambient temperature; once received, store at -20°C

Regulatory/Compliance

Manufactured in a facility that adheres to cGMP guidelines

Safety Information

Refer to provided MSDS

COA & Documents

Independent lot testing

Tesamorelin 20mg Certificate of Analysis

This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.

Lot number
80804
Report number
IF-824-QSA-TR006-2026-127-60
Date tested
March 2, 2026
Reported purity
99.8%
Labeled content
20 mg
DOWNLOADABLE RESOURCES

Product documents

Product information and laboratory resources. For lot-specific results, use the COA above.

PDF

Product & packaging information

Labeled amount, physical form and packaging for Tesamorelin 20mg.

Revision 0.4 · 2026-10-05Download PDF
PDF

Laboratory handling guide

General guidance for applicable lyophilized research materials. Not a product-specific SDS.

Revision 1.0 · 2026-09-22Download PDF
General guides & resources

Need Assistance?

Questions about product documentation?

Contact our support team for help with product records, lot information, orders or certificate verification.

Contact Support